177 related articles for article (PubMed ID: 31169978)
1. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
[TBL] [Abstract][Full Text] [Related]
2. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
Nat Commun; 2013; 4():1790. PubMed ID: 23653202
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate.
Oslund RC; Su X; Haugbro M; Kee JM; Esposito M; David Y; Wang B; Ge E; Perlman DH; Kang Y; Muir TW; Rabinowitz JD
Nat Chem Biol; 2017 Oct; 13(10):1081-1087. PubMed ID: 28805803
[TBL] [Abstract][Full Text] [Related]
4. Targeting PGAM1 in cancer: An emerging therapeutic opportunity.
Yang GJ; Tao F; Zhong HJ; Yang C; Chen J
Eur J Med Chem; 2022 Dec; 244():114798. PubMed ID: 36215859
[TBL] [Abstract][Full Text] [Related]
5. Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance.
Li N; Liu X
Onco Targets Ther; 2020; 13():1787-1795. PubMed ID: 32161473
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulation reveals how phosphorylation of tyrosine 26 of phosphoglycerate mutase 1 upregulates glycolysis and promotes tumor growth.
Wang Y; Cai WS; Chen L; Wang G
Oncotarget; 2017 Feb; 8(7):12093-12107. PubMed ID: 28076845
[TBL] [Abstract][Full Text] [Related]
8. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
9. Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
Wen YA; Zhou BW; Lv DJ; Shu FP; Song XL; Huang B; Wang C; Zhao SC
Asian J Androl; 2018; 20(2):178-183. PubMed ID: 29271400
[TBL] [Abstract][Full Text] [Related]
10. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
[TBL] [Abstract][Full Text] [Related]
11. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis.
Weng Y; Duan W; Yu X; Wu F; Yang D; Jiang Y; Wu J; Wang M; Wang X; Shen Y; Zhang Y; Xu H
Cancer Sci; 2023 Jun; 114(6):2345-2359. PubMed ID: 36880587
[TBL] [Abstract][Full Text] [Related]
13. PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells.
Feng Y; Zhang X; Zhang S; Xu S; Chen X; Zhou C; Xi Y; Xie X; Lu W
Front Biosci (Landmark Ed); 2022 Sep; 27(9):262. PubMed ID: 36224008
[TBL] [Abstract][Full Text] [Related]
14. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
[TBL] [Abstract][Full Text] [Related]
15. Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
Peng XC; Gong FM; Chen Y; Qiu M; Cheng K; Tang J; Ge J; Chen N; Zeng H; Liu JY
J Proteomics; 2016 Jan; 132():85-92. PubMed ID: 26655504
[TBL] [Abstract][Full Text] [Related]
16. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.
Li X; Tang S; Wang QQ; Leung EL; Jin H; Huang Y; Liu J; Geng M; Huang M; Yuan S; Yao XJ; Ding J
Front Pharmacol; 2017; 8():325. PubMed ID: 28611670
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation.
Hallows WC; Yu W; Denu JM
J Biol Chem; 2012 Feb; 287(6):3850-8. PubMed ID: 22157007
[TBL] [Abstract][Full Text] [Related]
19. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
[TBL] [Abstract][Full Text] [Related]
20. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
